Abstract The nitric oxide (NO) signaling pathway is integrally involved in visual processing and changes in the NO pathway are measurable in eyes of diabetic patients. The small peptide adrenomedullin (ADM) can activate a signaling pathway to increase the enzyme activity of neuronal nitric oxide synthase (nNOS). ADM levels are elevated in eyes of diabetic patients and therefore, ADM may play a role in the pathology of diabetic retinopathy. The goal of this research was to test the effects of inhibiting the ADM/NO signaling pathway in early diabetic retinopathy. Inhibition of this pathway decreased NO production in high-glucose retinal cultures. Treating diabetic mice with the PKC β inhibitor ruboxistaurin for 5 weeks lowered ADM mRNA levels and ADM-like immunoreactivity and preserved retinal function as assessed by electroretinography. The results of this study indicate that inhibiting the ADM/NO signaling pathway prevents neuronal pathology and functional losses in early diabetic retinopathy.
enzyme              0.9951040432502936^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

retinal                       0.9998945961439871^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Retina                

ADM                           0.9395247682420114^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Archer_Daniels_Midland

inhibitor                     0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

nitric oxide                  0.9999999999998863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nitric_oxide          

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

mRNA                          0.9999999999472493^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Messenger_RNA         

ADM                           0.9395247682420114^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Archer_Daniels_Midland

visual processing             0.9998323876988041^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Visual_system         

pathology                     0.8695008018516188^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

pathology                     0.8695008018516188^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

retinal                       0.9998945961439871^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Retina                

nNOS                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/NOS1                  

peptide                       0.9999999984440819^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Peptide               

PKC                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Protein_kinase_C      

ADM                           0.9395247682420114^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Archer_Daniels_Midland

adrenomedullin                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Adrenomedullin        

neuronal nitric oxide synthase1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/NOS1                  

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

diabetic                      0.999869522107698^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Diabetes_mellitus     

diabetic                      0.999869522107698^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Diabetes_mellitus     

immunoreactivity              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Immunoassay           

ADM                           0.9395247682420114^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Archer_Daniels_Midland

diabetic                      0.999869522107698^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Diabetes_mellitus     

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

ADM                           0.9395247682420114^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Archer_Daniels_Midland

electroretinography           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Electroretinography   

ADM                           0.9395247682420114^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Archer_Daniels_Midland

